Skip to main content
Fig. 2 | Cancer Cell International

Fig. 2

From: SFRP1 increases TMPRSS2-ERG expression promoting neoplastic features in prostate cancer in vitro and in vivo

Fig. 2

Effect of SFRP1 on AR target gene expression. KLK3 (PSA) expression after SFRP1 treatment, ****p ≤ 0.0001, *p ≤ 0.01, (ac). Effect of exogenous SFRP1 on ERG expression *p ≤ 0.05, **p ≤ 0.005 (df). AR localization by Immunofluorescence. Red (DAPI) and green (AR), (g). Expression of AR, **p ≤ 0.01 (h). Cells were treated with DHT and SFRP1 for 24 h (0.01 nM)

Back to article page